These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11876472)

  • 1. Screening with tumor markers: critical issues.
    Roulston JE
    Mol Biotechnol; 2002 Feb; 20(2):153-62. PubMed ID: 11876472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers. An update.
    Pamies RJ; Crawford DR
    Med Clin North Am; 1996 Jan; 80(1):185-99. PubMed ID: 8569297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
    Verma M; Manne U
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in using tumor markers: what the psycho-oncologist needs to know.
    Fertig DL; Hayes DF
    Psychooncology; 2001; 10(5):370-9. PubMed ID: 11536415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cancer: evaluating the evidence.
    Gates TJ
    Am Fam Physician; 2001 Feb; 63(3):513-22. PubMed ID: 11272300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges to cancer control by screening.
    Pollak MN; Foulkes WD
    Nat Rev Cancer; 2003 Apr; 3(4):297-303. PubMed ID: 12671668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for ovarian cancers: critical analysis].
    Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
    Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design issues in cancer screening trials.
    Moss S
    Stat Methods Med Res; 2010 Oct; 19(5):451-61. PubMed ID: 20442197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Theoretical conditions for cancer screening. Example of prostate cancer].
    Irani J
    Prog Urol; 1999 Jun; 9(3):435-9. PubMed ID: 10434314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for serum tumor markers continues.
    McIntosh H
    J Natl Cancer Inst; 1992 Mar; 84(6):387-9. PubMed ID: 1538415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biomarker screening for early detection of cancer].
    Wiedemann GJ
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):43-5. PubMed ID: 23250696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers as surrogates for cancer development.
    Hawk E; Viner JL; Lawrence JA
    Curr Oncol Rep; 2000 May; 2(3):242-50. PubMed ID: 11122849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.
    Wang Y; Jiang X; Dong S; Shen J; Yu H; Zhou J; Li J; Ma H; He E; Skog S
    Cancer Biomark; 2016 Mar; 16(4):529-36. PubMed ID: 27002755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phases of biomarker development for early detection of cancer.
    Pepe MS; Etzioni R; Feng Z; Potter JD; Thompson ML; Thornquist M; Winget M; Yasui Y
    J Natl Cancer Inst; 2001 Jul; 93(14):1054-61. PubMed ID: 11459866
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening and early diagnosis of colorectal cancer in China: a 12 year retrospect (1994-2006).
    Li S; Wang J; Lu Y; Fan D
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):679-86. PubMed ID: 17503079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for malignant neoplasms by using the new method of marker diagnosis, the Oncotest].
    Suslov EI; Galakhin KA; Vladimirov VA; Morozov AA; Vishnevskiĭ VV
    Lik Sprava; 1997; (1):99-103. PubMed ID: 9221159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening: the old and the new.
    Ziebert JJ
    Tex Med; 2001 Feb; 97(2):46-8. PubMed ID: 11233058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.